Glaxo

(AP Photo)

FDA weighs lifting safety restrictions on Avandia

WASHINGTON (AP) — A former blockbuster diabetes pill which was subjected to major safety restrictions in 2010 may not be as risky as once thought, according to the latest analysis of the much-debated GlaxoSmithKline drug […]

06/03/2013